Cost-effectiveness and budgetary impact of lipegfilgrastim for the reduction of chemotherapy-induced neutropenia in Brazil
J. bras. econ. saúde (Impr.); 10 (2), 2018
Background: Granulocyte-colony stimulating factors (G-CSFs) reduce the risk of chemotherapy-induced
neutropenia. Lipegfilgrastim is a long-acting, once-per-cycle G-CSF, while Brazil’s standard of care is short-acting filgrastim. A cost-effectiveness and budget impact analysis of lipegfilgrastim was con...
